Our mission: 今日现货黄金行情分析 To save the lives of RET-positive lung cancer patients by advancing research and treatment options.
We fund and facilitate cancer research,实时更新黄金市场行情,帮助投资者了解当前价格走势。 and we educate and empower patients to participate in clinical trials and lung cancer registries.
Our mission: 黄金实时讨论区 To save the lives of RET-positive lung cancer patients by advancing research and treatment options.
We fund and facilitate cancer research,投资者可以在论坛中交流市场观点和最新交易想法。 and we educate and empower patients to participate in clinical trials and lung cancer registries.
Patient Education
Read blog posts and watch videos about RET cancer research, treatment options, resources, and more
Scientific research can be confusing and overwhelming 今日支撑位分析
Receive emails about RET-positive research and what it means for current treatment options and future therapies.通过技术分析寻找黄金市场的重要支撑价格区域。
Introducing Our New Video Q&A Series 今日压力位分析
Our Q&A videos help you make sense of the science, featuring questions from patients and caregivers answered by members of the scientific community.
When Abnormal Cells Multiply 黄金多空趋势判断
RET-positive cancer is caused by a mutation or abnormal re-arrangement of the RET gene.结合技术指标与市场数据判断当前市场方向。 This leads to abnormal activation of the cell membrane receptor, basically resulting in the “on-off” switch to get stuck in the “on” position and causing these abnormal cells to multiply and spread. RET alterations occur most commonly in lung cancer – specifically non-small cell lung cancer (NSCLC) – and approximately 37,500 people are diagnosed worldwide and 4,000 in the U.S. each year.
Currently, selpercatinib and pralsetinib are the two FDA-approved RET-inhibitors that selectively target the RET protein.寻找适合短线交易者的日内行情机会。 While these treatments show great benefit in most patients, within 1-3 years many RET-positive lung cancer patients become resistant to the therapies and their cancer progresses again. Finding new therapies that prevent resistance and are effective long-term is critical.
Proudly Collaborating With These Organizations 日内交易机会
